Schedule 13G ownership disclosure

ProQR Therapeutics NV

Security class unavailable · CUSIP: N71542109

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,297,270
Percent of class
6.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000769993-21-000129
Form type
SC 13G/A
Filer
GOLDMAN SACHS & CO. LLC
CIK
CIK 769993
Filed
Feb 12, 2021
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub